FAIRLANE, a double-blind placebo-controlled randomized phase II trial of neoadjuvant ipatasertib plus paclitaxel for early triple-negative breast cancer

1. Oliveira, M.
2. Saura, C.
3. Nuciforo, P.
4. Calvo, I.
5. Andersen, J.
6. Passos-Coelho, J.L.
7. Gil Gil, M.
8. Bermejo, B.
9. Patt, D.A.
10. Ciruelos, E.
11. De La Peña, L.
12. Xu, N.
13. Wongchenko, M.
14. Shi, Z.
15. Singel, S.M.
16. Isakoff, S.J.